LucoDac (Dacomitinib) 15mg/45mg*30's | Generic EGFR Inhibitor | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Share
Product description

Generic Information: LucoDac (Laos)

LucoDac is a generic dacomitinib manufactured by Lucius Pharmaceuticals in Laos. It is offered in two strengths — 15 mg and 45 mg — each in a 30-tablet box, which mirrors the strength range of the originator brand. As a generic second-generation EGFR inhibitor, LucoDac contains the same active ingredient as the branded product and is positioned as a lower-cost alternative for patients who are paying out of pocket for EGFR-mutated lung cancer therapy.

What Is LucoDac Used For?

LucoDac is used for the first-line treatment of non-small cell lung cancer (NSCLC) with EGFR exon 19 deletion or exon 21 L858R substitution mutations. Patients who have had their tumor tested and confirmed to carry one of these sensitizing mutations are the target population. It is a monotherapy taken by mouth, which keeps treatment simple and home-based.

How Does LucoDac (Dacomitinib) Work?

The active ingredient dacomitinib works as an irreversible inhibitor of EGFR, HER2, and HER4, permanently blocking the signaling that fuels EGFR-mutated cancer cells. This pan-HER, covalent mechanism gives it a longer-lasting effect than first-generation EGFR inhibitors, and it remains active against some mutations where first-generation drugs fall short. The generic LucoDac delivers the same pharmacology as the originator at a lower price.

Indications

LucoDac is indicated for adults with locally advanced or metastatic NSCLC whose tumors harbor an EGFR exon 19 deletion or an exon 21 L858R mutation. It is not suitable for patients without an EGFR mutation, and it is not indicated for small-cell lung cancer. A physician should confirm the mutation by genetic testing before the medicine is prescribed.

Dosage

The recommended dose is 45 mg once daily. The 15 mg strength is available for dose reduction when side effects require it. LucoDac should be taken at roughly the same time every day, with or without food. If a dose is forgotten, take the next dose on schedule without doubling up. Avoid combining it with proton-pump inhibitors; if acid control is needed, use an antacid or H2-receptor antagonist with proper timing.

Side Effects

The typical side-effect profile of dacomitinib includes diarrhea, skin rash, paronychia, mouth ulcers, reduced appetite, dry skin, weight loss, hair thinning, cough, and itching. Most of these are manageable with supportive care, dose adjustment, and early intervention. Serious effects such as interstitial lung disease are uncommon but require immediate medical attention and permanent discontinuation if confirmed.

Storage

Store LucoDac below 30°C in a dry place, in its original packaging, and keep it away from children. There is no need for cold-chain handling.

Why Choose the GLT?

For patients paying out of pocket, a generic like LucoDac from Laos offers a meaningful price advantage over the originator brand. While the originator list price in Western markets is very high, Lao generic dacomitinib is priced far more affordably, which can make long-term, daily therapy financially sustainable. GLT sources from verified manufacturers and helps buyers obtain the documentation they need for safe import.

How to Order

To order LucoDac through GLT, contact us on WhatsApp at +86 15234153837 or email [email protected]. Let us know whether you need 15 mg or 45 mg, the number of boxes, and your destination, and we will confirm availability, sourcing, and shipping terms for your region.

FAQ

Is LucoDac the same as Vizimpro? LucoDac is a generic version of dacomitinib, the same active ingredient as Vizimpro, but produced by a different manufacturer in Laos. The pharmacology is equivalent, while the price is lower.

Can I buy generic dacomitinib online? Many patients source generic dacomitinib through international suppliers like GLT. Always confirm the supplier is legitimate and provides proper documentation before ordering.

Is LucoDac available in two strengths? Yes, LucoDac is available in 15 mg and 45 mg tablets, each in 30-tablet packs, matching the two most common dosing needs.

Related Oncology Products

Tixepa (Tirzepatide) 20mg/2mL & 30mg/2mL Multi-Dose Pen | Drug International | GLT

Tixepa — Drug International Limited (DIL) tirzepatide multi-dose pen, two official strengths (Tixepa-5 = 20mg/2mL,...

Orforglipron (OriYo) 0.8–17.2mg Tablets | Bangladesh Generic Oral GLP-1 | GLT

National Drug Co. generic orforglipron, 6-dose titration for weight management

Baricent (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Incepta Pharmaceuticals Ltd. | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Incepta Pharmaceuticals Ltd. (Bangladesh) — an affordable alternative to Olumiant...

Zepbound (Tirzepatide) 2.5–15mg/0.5mL Single-Dose Pen | Eli Lilly USA | GLT

Zepbound — Eli Lilly tirzepatide single-dose pen, six US strengths (2.5–15mg/0.5mL) for chronic weight management...

SPINRAZA (Nusinersen) 12mg/5mL | Buy from China | SMA Therapy | GLT

Biogen's first-in-class antisense oligonucleotide for SMA, NMPA-approved and nationally reimbursed in China — buy from...

AVATODX (Avatrombopag) 20mg*30 Tablets | Bigbear Pharmaceutical Laos | GLT

AVATODX — avatrombopag 20mg by Bigbear Pharmaceutical (Lao) Co., Ltd., Lao Reg. 06L0985/23, 30-tablet bottle

Avabopa (Avatrombopag) 20mg*30 Tablets | Tongmeng TLPH Laos | GLT

Avabopa — avatrombopag 20mg by Tongmeng (Lao) Pharmaceutical and Food Co., Ltd. (TLPH), Lao Reg....

KangQuXin 康曲欣 (Avatrombopag) 20mg*10 Tablets | Beijing Continent Gyre | GLT

KangQuXin — avatrombopag by Beijing Continent Pharmaceutical (Gyre Therapeutics, Nasdaq: GYRE), China Mainland